Iovance Biotherapeutics targets significant market expansion, with lung cancer representing a $10B U.S. peak sales ...

Southpoint Capital Advisors, acting on behalf of certain Southpoint funds disposed of beneficial ownership of 1M shares of Fennec Pharmaceuticals (FENC) at a price of $7.50.

According to the Summary of Opinions from the December meeting, the Bank of Japan ((BoJ)) believes that incrementally ...

Hercules Capital's GAAP NII-to-distribution spread has ensured reliable base and supplemental dividends. Read why HTGC stock ...

Discover why TALO offers 26% upside potential with strong growth, strategic backing, and undervaluation versus peers.

Salesforce is undergoing a pivotal AI-driven transformation with Agentforce and is expected to accelerate revenue growth.

Discover if Calamos Dynamic Convertible and Income Fund (CCD) is right for you. Learn about its 10.8% yield, risks, and tax ...

EPR Properties (EPR) is upgraded from 'sell' to 'buy' after a 16% price drop and rapid portfolio de-risking. EPR's aggressive ...

Discover why Bilibili (BILI) is a buy: surging user growth, rising ad revenue, robust cash, and global game launches.

Explore the outlook for Invesco Senior Loan ETF (BKLN): get insights on rates, credit risk, and income potential.

Discover how an inflation-focused asset allocation model is evolving for 2026 with added diversification using all-weather ...

Hecla Mining benefits from Tier-1 jurisdiction assets, record revenues, and increasing production. Read why HL stock is ...